George Robertson
Surgery · Lebanon, TNNPI 1275591935
Payments from drug & device makers
Across 259 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- GSK$544
- Lilly USA, LLC$318
- Nestle Healthcare Nutrition Inc.$276
- AstraZeneca$273
- Amgen$233
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 77 | $1,309 |
| GSK | 33 | $544 |
| Lilly USA, LLC | 22 | $318 |
| Nestle Healthcare Nutrition Inc. | 15 | $276 |
| AstraZeneca | 15 | $273 |
| Amgen | 15 | $233 |
| Xeris Pharmaceuticals, Inc. | 12 | $190 |
| Bayer | 8 | $139 |
| Johnson & Johnson | 7 | $112 |
| Boehringer Ingelheim | 6 | $101 |
| Kowa Pharmaceuticals America, Inc. | 4 | $99 |
| Inspire Medical Systems, Inc. | 1 | $94 |
| Novartis | 5 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| AbbVie | 3 | $61 |
| Amarin Pharma, Inc. | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $52 |
| Astellas Pharma US Inc | 3 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Eisai Inc. | 2 | $32 |
| Exact Sciences | 2 | $30 |
| Merck | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Pfizer | 1 | $23 |
| Boston Scientific | 1 | $22 |
| Abbott | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Kerecis Limited | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Cequr Corporation | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Radius Health, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,479 in reported general payments places this provider in the 60th percentile of 516 surgery providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 14 | $13,002 |
| Levothyroxine Sodium | 12 | $136 |
| Atorvastatin Calcium | 11 | $84 |
| Omeprazole | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $318 | $13,00214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 516 surgery providers in Tennessee.
Other surgery in Lebanon
- Evelio RodriguezNashville$2.5M
- Heath BroussardJackson$688K
- Eric WallaceCookeville$529K
- Guy VoellerMemphis$434K
- John RobertsonJohnson City$432K
- Jaime Ponce-PortugalChattanooga$412K
- Robert MaxwellChattanooga$393K
- Mathew NinanNashville$298K
- Richard PierceNashville$276K
- Joseph BroucekNashville$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.